To view or add a comment, sign in More Relevant Posts Despite Covered Entities and numerous trade associations having raised significant legal, administrative and financial concerns with shifting a discount program to a rebate program, the HRSA approved 8 drug manufacturers / 9 drugs for participation in the 340B Rebate Model Pilot Program
One of the most prominent issues is the high rate of adverse events such as nausea, diarrhea, constipation, abdominal pain, and other gastrointestinal adverse effects
NICE Technology Appraisal guidance (TA875 for semaglutide/Wegovy and TA664 for liraglutide/Saxenda) recommends these medications for weight management in adults with: A body mass index (BMI) of at least 35 kg/m and At least one weight-related comorbidity (such as type 2 diabetes, hypertension, dyslipidaemia, obstructive sleep apnoea, or non-alcoholic fatty liver disease) For liraglutide (Saxenda), NICE TA664 specifies additional criteria including prediabetes (HbA1c 42-47 mmol/mol or fasting plasma glucose 5.5-6.9 mmol/L) or high risk of cardiovascular disease
Cortez-Pinto H, Chatham J, Chacko VP, Arnold C, Rashid A, Diehl AM
Exposure to pesticides causes alteration of the inflammatory pathway (Nrf2/NF-kB, MAPKs/PI3K, and Akt/GSK3) reducing NF-E2related factor (Nrf)2, increasing NF-kB, and opening voltage-gated Ca2 + channel of the neurons plasmatic membrane (Silver et al., 2017), leading to oxidative stress, neuronal apoptosis e reduction of serotonin
When to Choose GHK-Cu vs